Melphalan/prednisone versus melphalan/prednisone plus human alpha interferon therapy in patients with multiple myeloma, stages II and III. Myeloma Group of Central Sweden.
Björkholm
M
M
Department of Medicine, Karolinska Hospital, Stockholm, Sweden.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D008558:Melphalan / Q000008:administration & dosage; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000401:mortality / Q000628:therapy*; D011241:Prednisone / Q000008:administration & dosage; D011446:Prospective Studies
D016898:Interferon-alpha; D008558:Melphalan; D011241:Prednisone